School of Veterinary Medicine

In a unique, interdisciplinary collaboration, the University of Pennsylvania School of Veterinary Medicine’s Working Dog Center, The School of Arts and Science's Department of Physics and Astronomy, Penn Medicine’s Division of Gynecologic Oncology and the Monell Chemical Senses Center have joined together to study ovarian cancer detection by dogs and e-sensors.

The American College of Veterinary Emergency and Critical Care (ACVECC) has approved Penn Vet’s Ryan Hospital as one of nine designated Veterinary Trauma Centers in the U.S. – and the only recognized 24/7 Veterinary Trauma Center within a 100 mile radius of Philadelphia. 

Deep brain stimulation (DBS) in a precise region of the brain appears to reduce caloric intake and prompt weight loss in obese animal models, according to a new study led by researchers at the University of Pennsylvania.

The University of Pennsylvania’s Sarah Hughes didn’t always consider herself an advocate. But she’s also not one to pass up an opportunity to help.

Gustavo Aguirre of the University of Pennsylvania School of Veterinary Medicine has received the International Canine Health Award from the

The Penn Institute for Urban Research (Penn IUR) hosts the 9th Annual Urban Leadership Forum on Wednesday March 13th from 5:30pm to 7:30pm to celebrate exemplary leaders in the effort to build resilient, food-secure, and livable cities.

Feeding Cities: Food Security in a Rapidly Urbanizing World, the first international conference examining the critical link between urbanization and food security, will be held at the University of Pennsylvania from Wednesday, March 13, through Friday, March 15, 2013.

PHILADELPHIA — Nicola Mason and Yvonne Paterson have been named this year’s recipients of the University of Pennsylvania

PHILADELPHIA — Researchers from the University of Pennsylvania School of Veterinary Medicine have discovered that a protein called Jagged-1 stimulates human stem cells to differentiate into bone-producing cells.

PHILADELPHIA — Niemann-Pick Type C disease is a rare and incurable neurological disorder that affects 500 children worldwide. Presently, there are no therapies approved by the U.S. Food and Drug Administration to treat NPC.